ROKU insider files Rule 144 to sell 10,269 shares on 09/04/2025
Rhea-AI Filing Summary
Form 144 notice for Roku, Inc. (ROKU): The filer proposes the sale of 10,269 common shares through Morgan Stanley Smith Barney LLC on 09/04/2025 with an aggregate market value of $1,018,079.96. The filing reports the shares were acquired on 09/04/2025 by stock option exercise from the issuer and paid in cash. The filing lists 147,330,633 shares outstanding for the class. The notice also discloses five prior sales by Charles Collier in the past three months totaling 252,948 shares sold on specific dates with gross proceeds reported for each sale.
Positive
- Full Rule 144 details provided including broker, acquisition method, sale date, and aggregate market value
- Recent three-month sales history disclosed (dates, amounts, and gross proceeds) for transparency
Negative
- Insider selling activity—multiple sales totaling 252,948 shares in the past three months which may be viewed negatively by some investors
- No disclosure of a 10b5-1 trading plan adoption date is provided in the remarks section
Insights
TL;DR: Insider sale disclosed: 10,269 shares to be sold on 09/04/2025 for about $1.02M; recent prior sales are disclosed.
The filing is a routine Rule 144 notice showing a proposed sale of shares acquired by option exercise the same day and being sold through Morgan Stanley Smith Barney LLC. Important facts are the number of shares to be sold, the stated aggregate market value, the reported shares outstanding, and the record of multiple recent sales by the same individual over the prior three months. For investors, this is transparent insider selling activity but the filing itself does not provide company operational or financial information.
TL;DR: Filing appears compliant with Rule 144 disclosure requirements and records recent insider sales and acquisition details.
The notice includes the required broker, sale date, acquisition method (stock option exercise), payment method (cash), and a history of sales in the prior three months by the named seller, satisfying key Rule 144 disclosure items. The signer represents no undisclosed material adverse information per the form language. The form does not include supplemental explanatory remarks or a 10b5-1 plan adoption date.